Kidney Failure, Chronic Clinical Trial
Official title:
Prevention of Peritonitis in Patients With Peritoneal Dialysis - Effects of Regular Follow-up of Patients´ Theoretical Knowledge and Practical Skills With Focus on Infection Prophylaxis
BACKGROUND: Peritonitis remains a significant problem in peritoneal dialysis. It is the
leading cause of technique failure, and contributes to mortality. The incidence is highest
during the first year of treatment. Non-compliance with the Peritoneal Dialysis (PD) protocol
is shown to be an important risk factor for peritonitis. Reinforcement of knowledge and
ability to perform PD therefore appears to be a possible way to reduce the incidence of
peritonitis. This will be studied in The PEritonitis Prevention Study (PEPS).
METHODS: The objective of this randomized, multi-centre investigation,which will include 750
new PD patients who can perform (PD) without assistance, is to evaluate if regular retraining
can reduce the incidence of peritonitis, the technique-failure rate, and the hospitalisation
days due to peritonitis compared with regular follow-up regimen. Patients in the intervention
group will tested by a PD-technique test and a questionnaire at regular intervals after
PD-start and after every peritonitis episode with focus on infection prophylaxis. If needed,
they will be retrained. The control group will be treated according to the routine of the
center.
The study is ongoing in Denmark, Norway, Sweden, Finland, Estonia, Latvia, the Netherlands,
and the UK. The study will go on for 6 years.
BACKGROUND See above. AIMS To study if regular follow-up of PD patients with testing of their
theoretical and practical knowledge (hereafter called "new type of follow-up") can reduce the
incidence of peritonitis, reduce the technique failure rate related to peritonitis, and
reduce the time of hospitalization related to peritonitis compared to a routine regimen. For
specific aims, see "Outcome measures" below.
PATIENTS AND METHODS The study is a randomized, multi-centre investigation intending to
enclose 750 new PD patients in Sweden, Denmark, Norway, Finland, Estonia, Latvia, the
Netherlands, and the United Kingdom. Inclsuion was finished on December 31, 2014. The study
will go on until the last included patient has taken part of the study for one year. The
study will thus be terminated on December 31, 2015.
The study includes a follow-up group and a control group. The intervention in the follow-up
group consists of regular testing of theoretical and practical knowledge regarding PD with
focus on infection prophylaxis including retraining if needed until the test goals are
reached. The control group will be treated according to the routines of the center.
Peritonitis is defined according to ISPD guidelines (Perit Dial Int 2005;25:107-131)
The baseline PD training will be the same at all participating centres and follow
international recommendations. In addition, fluorescent alcohol and a UV lamp will be used to
control the result of hand disinfection in all patients once during the initial PD training.
Thereafter this method will only be used in the follow-up group.
In the follow-up group, the knowledge from the basal training will be tested at 1, 3, 6, and
12 months after PD start, every sixth month thereafter, and after every episode of
peritonitis. Such testing will also be performed at restart of PD. The follow-up includes two
types of tests:
1. The patient will fill in a questionnaire with theoretical and practical questions with
focus on infection and infection prophylaxis during PD treatment. Goal: At least 80% of
the questions should be correct. If the goal is not reached, further training will be
given until the goal is reached.
2. The patient will perform a practical test including hand disinfection, PD exchange
technique, and exit-site care. Hand disinfection skills will be controlled with the help
of fluorescent alcohol and a UV lamp. Goal: All steps of the practical test should be
correctly performed. If not, further training will be given until the goal is reached.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246984 -
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
|
N/A | |
Completed |
NCT02922361 -
Spending and Outcomes for Complex Medicare Advantage Patients
|
||
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Completed |
NCT01930396 -
Use of Tinzaparin for Anticoagulation in Hemodialysis
|
Phase 4 | |
Completed |
NCT01933789 -
Improving Communication About Serious Illness
|
N/A | |
Completed |
NCT01922843 -
A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
|
Phase 2 | |
Not yet recruiting |
NCT01674660 -
Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients
|
N/A | |
Completed |
NCT01209403 -
Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
|
Phase 4 | |
Not yet recruiting |
NCT01157260 -
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00534144 -
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
|
Phase 1 | |
Completed |
NCT00528788 -
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
|
Phase 4 | |
Completed |
NCT00226902 -
Vascular Reactivity in Kidney Disease Patients
|
N/A | |
Completed |
NCT00382044 -
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
|
N/A | |
Recruiting |
NCT00235287 -
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00224081 -
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
|
Phase 4 | |
Completed |
NCT00071214 -
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
|
Phase 3 | |
Completed |
NCT00049907 -
Cardiac and Renal Disease Study (CARDS)
|
N/A | |
Completed |
NCT00006297 -
Risk Factors for CV Disease in a Dialysis Cohort
|
N/A |